German regulators reject Lecanemab and Donanemab as no added value over standard care
New research confirms early dementia signs may appear in gut bacteria years before memory loss, offering hope for blood-based screening while costly antibody therapies fail to improve daily functioning. Gut microbiome changes predict cognitive decline with 79 percent accuracy in UEA study Scientists at the University of East Anglia analyzed stool and blood samples from … Weiterlesen …
